Bloomberg Law Analysis
View and Filter All Stories

Latest Stories

ANALYSIS: Lawyers, Take a Moment for Self-Care. It’s Free!

How are you feeling these days? Many lawyers are struggling just to feel “OK.” Well-being is foundational to working effectively, and with lawyer well-being week right around the corner, we want to revisit content that Bloomberg Law makes freely available to support lawyers in their growth, development and well-being.

ANALYSIS: FTC Rethinks Pharma M&A After a Decade of Mega Deals

The Federal Trade Commission has not blocked a single pharmaceutical mega deal in the past decade. Our research found that the FTC imposed conditions and divestitures on fewer than one-third of these $10 billion-plus deals, all of which subsequently closed. The current FTC is rethinking that outcome.

ANALYSIS: Accellion Hack Reveals Drafting Risks in Cloud Deals

Health care company Centene’s recent breach of contract complaint against Accellion, a cloud solutions company that suffered a sophisticated cyberattack over the winter, serves as a warning bell for similarly positioned service providers. Now may be the time to re-examine strategies for negotiating data breach indemnity clauses.

View More
Made with Flourish

Corporate Transactions: Leading the Strategy

Bloomberg Law Analysts talk about trends they see in corporate transactions.

Up Next

Insights from Bloomberg Law’s Legal Operations & Technology survey

The Privacy Landscape


In the #MeToo Era, Policies Are Not Enough

What If the Feds Legalize Cannabis?